These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 23617687)

  • 1. Preventing hospital admissions by reviewing medication (PHARM) in primary care: an open controlled study in an elderly population.
    Leendertse AJ; de Koning GH; Goudswaard AN; Belitser SV; Verhoef M; de Gier HJ; Egberts AC; van den Bemt PM
    J Clin Pharm Ther; 2013 Oct; 38(5):379-87. PubMed ID: 23617687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a pharmacist-led structured medication review in primary care on drug-related problems and hospital admission rates: a randomized controlled trial.
    Lenander C; Elfsson B; Danielsson B; Midlöv P; Hasselström J
    Scand J Prim Health Care; 2014 Dec; 32(4):180-6. PubMed ID: 25347723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Home-based medication review in a high risk elderly population in primary care--the POLYMED randomised controlled trial.
    Lenaghan E; Holland R; Brooks A
    Age Ageing; 2007 May; 36(3):292-7. PubMed ID: 17387123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical medication review by a pharmacist of elderly people living in care homes--randomised controlled trial.
    Zermansky AG; Alldred DP; Petty DR; Raynor DK; Freemantle N; Eastaugh J; Bowie P
    Age Ageing; 2006 Nov; 35(6):586-91. PubMed ID: 16905764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT).
    Hazen AC; Sloeserwij VM; Zwart DL; de Bont AA; Bouvy ML; de Gier JJ; de Wit NJ; Leendertse AJ
    BMC Fam Pract; 2015 Jul; 16():76. PubMed ID: 26135582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implementation of systematic medication reconciliation and review as part of the Lund Integrated Medicines Management model--impact on all-cause emergency department revisits.
    Hellström LM; Höglund P; Bondesson A; Petersson G; Eriksson T
    J Clin Pharm Ther; 2012 Dec; 37(6):686-92. PubMed ID: 22924464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing hospital admissions by reviewing medication (PHARM) in primary care: design of the cluster randomised, controlled, multi-centre PHARM-study.
    Leendertse AJ; de Koning FH; Goudswaard AN; Jonkhoff AR; van den Bogert SC; de Gier HJ; Egberts TC; van den Bemt PM
    BMC Health Serv Res; 2011 Jan; 11():4. PubMed ID: 21214918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication reviews in the community: results of a randomized, controlled effectiveness trial.
    Sorensen L; Stokes JA; Purdie DM; Woodward M; Elliott R; Roberts MS
    Br J Clin Pharmacol; 2004 Dec; 58(6):648-64. PubMed ID: 15563363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of medication review and cognitive behaviour treatment by community pharmacists of patients discharged from the hospital on drug related problems and compliance: design of a randomized controlled trial.
    Ahmad A; Hugtenburg J; Welschen LM; Dekker JM; Nijpels G
    BMC Public Health; 2010 Mar; 10():133. PubMed ID: 20230611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of a clinical medication review and a pharmaceutical care plan of polypharmacy patients with a cardiovascular disorder.
    Geurts MM; Stewart RE; Brouwers JR; de Graeff PA; de Gier JJ
    Int J Clin Pharm; 2016 Aug; 38(4):808-15. PubMed ID: 27052212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of pharmacist counseling in preventing adverse drug events after hospitalization.
    Schnipper JL; Kirwin JL; Cotugno MC; Wahlstrom SA; Brown BA; Tarvin E; Kachalia A; Horng M; Roy CL; McKean SC; Bates DW
    Arch Intern Med; 2006 Mar; 166(5):565-71. PubMed ID: 16534045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication reconciliation for reducing drug-discrepancy adverse events.
    Boockvar KS; Carlson LaCorte H; Giambanco V; Fridman B; Siu A
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):236-43. PubMed ID: 17062324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cost-consequences analysis of an adherence focused pharmacist-led medication review service.
    Desborough JA; Sach T; Bhattacharya D; Holland RC; Wright DJ
    Int J Pharm Pract; 2012 Feb; 20(1):41-9. PubMed ID: 22236179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality use of medicines in the rural ambulant elderly: a pilot study.
    Graffen M; Kennedy D; Simpson M
    Rural Remote Health; 2004; 4(3):184. PubMed ID: 15885009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving medication safety: influence of a patient-specific prescriber feedback program on rate of medication reviews performed by Australian general medical practitioners.
    Roughead E; Pratt N; Peck R; Gilbert A
    Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):797-803. PubMed ID: 17476702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands.
    Leendertse AJ; Egberts AC; Stoker LJ; van den Bemt PM;
    Arch Intern Med; 2008 Sep; 168(17):1890-6. PubMed ID: 18809816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial.
    Holland R; Lenaghan E; Harvey I; Smith R; Shepstone L; Lipp A; Christou M; Evans D; Hand C
    BMJ; 2005 Feb; 330(7486):293. PubMed ID: 15665005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacist consultations in general practice clinics: the Pharmacists in Practice Study (PIPS).
    Tan EC; Stewart K; Elliott RA; George J
    Res Social Adm Pharm; 2014; 10(4):623-32. PubMed ID: 24095088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a ward-based pharmacy team on preventable adverse drug events in surgical patients (SUREPILL study).
    Surgery and Pharmacy in Liaison (SUREPILL) Study Group
    Br J Surg; 2015 Sep; 102(10):1204-12. PubMed ID: 26179814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of a transitional pharmaceutical care program on the occurrence of ADEs after discharge from hospital in patients with polypharmacy.
    Uitvlugt EB; Heer SE; van den Bemt BJF; Bet PM; Sombogaard F; Hugtenburg JG; van den Bemt PMLA; Karapinar-Çarkit F
    Res Social Adm Pharm; 2022 Apr; 18(4):2651-2658. PubMed ID: 34049802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.